Literature DB >> 28651210

Associations between perfluorinated alkyl acids in blood and ovarian follicular fluid and ovarian function in women undergoing assisted reproductive treatment.

Jessica A McCoy1, Jacqueline T Bangma1, Jessica L Reiner2, John A Bowden2, John Schnorr3, Michael Slowey3, Thomas O'Leary4, Louis J Guillette5, Benjamin B Parrott6.   

Abstract

Endocrine disrupting contaminants, in combination with other environmental variables, are associated with altered reproductive health. Assisted reproductive technology (ART) procedures offer valuable opportunities to explore the connections between environmental contaminants in the ovarian microenvironment and measures of fertility, including impaired responsiveness to gonadotropins. Here, we investigate an emerging class of environmental contaminants, the perfluorinated alkyl acids (PFAAs), to determine whether ovarian contaminant levels are associated with measures of ovarian responsiveness and fertility outcomes in a South Carolina population of women undergoing ART. Levels of PFAAs in plasma and follicular fluid samples collected from women undergoing ovarian stimulation were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS). Six PFAAs were detected in both plasma and follicular fluid. PFAA concentrations in plasma correlate strongly to those detected in ovary and, with the exception of one compound, remain stable throughout ovarian stimulation. The concentration of PFHxS in follicular fluid inversely relates to baseline follicle counts. While no significant relationships were detected between ovarian response measures and PFAA concentrations, we identified a negative relationship between follicular fluid PFDA and PFuNA and blastocyst conversion rates. Our assessments indicate that plasma levels of PFAAs serve as a sound proxy of those in the ovarian compartment and that follicular fluid levels of specific PFAA compounds are inversely related to important clinical measures of reproductive health including baseline follicle count and post-fertilization success.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ART; EDCs; Follicular fluid; PFAAs

Mesh:

Substances:

Year:  2017        PMID: 28651210     DOI: 10.1016/j.scitotenv.2017.06.137

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park
Journal:  Hum Reprod Update       Date:  2020-09-01       Impact factor: 15.610

2.  Effects of Environmental EDCs on Oocyte Quality, Embryo Development, and the Outcome in Human IVF Process.

Authors:  Xiaoming Xu; Mei Yang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Perfluorooctanoic Acid Disrupts Ovarian Steroidogenesis and Folliculogenesis in Adult Mice.

Authors:  May Yang; Yuna Lee; Liying Gao; Karen Chiu; Daryl D Meling; Jodi A Flaws; Genoa R Warner
Journal:  Toxicol Sci       Date:  2022-03-28       Impact factor: 4.849

4.  Chronic exposure to perfluorohexane sulfonate leads to a reproduction deficit by suppressing hypothalamic kisspeptin expression in mice.

Authors:  Xiaorui Yin; Tingting Di; Xinyuan Cao; Zhengnan Liu; Jingyan Xie; Suyun Zhang
Journal:  J Ovarian Res       Date:  2021-10-27       Impact factor: 4.234

5.  Per- and Polyfluoroalkyl Substances and Hormone Levels During the Menopausal Transition.

Authors:  Siobán D Harlow; Michelle M Hood; Ning Ding; Bhramar Mukherjee; Antonia M Calafat; John F Randolph; Ellen B Gold; Sung Kyun Park
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

6.  Resolvin E1 in Follicular Fluid Acts as a Potential Biomarker and Improves Oocyte Developmental Competence by Optimizing Cumulus Cells.

Authors:  Yijing Zhang; Zhongyi Zhu; He Li; Mingjiang Zhu; Xiandong Peng; Aijie Xin; Ronggui Qu; Wen He; Jing Fu; Xiaoxi Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-16       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.